ATE469899T1 - Spiropiperidinderivate - Google Patents

Spiropiperidinderivate

Info

Publication number: ATE469899T1
Authority: AT; Austria
Prior art keywords: spiropiperidine derivatives; spiropiperidine; derivatives
Prior art date: 2006-12-07

Application number

AT07847384T

Other languages

English (en)

Inventor

Caterina Bissantz

Christophe Grundschober

Raffaello Masciadri

Hasane Ratni

Mark Rogers-Evans

Patrick Schnider

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-12-07

Filing date

2007-11-27

Publication date

2010-06-15

2007-11-27 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2010-06-15 Application granted granted Critical

2010-06-15 Publication of ATE469899T1 publication Critical patent/ATE469899T1/de

Links

JUXAVSAMVBLDKO-UHFFFAOYSA-N 1-(1-azabicyclo[2.2.2]octan-3-yl)-3-[3-(1h-indol-3-yl)-1-oxo-1-spiro[1,2-dihydroindene-3,4'-piperidine]-1'-ylpropan-2-yl]urea Chemical class C1N(CC2)CCC2C1NC(=O)NC(C(=O)N1CCC2(C3=CC=CC=C3CC2)CC1)CC1=CNC2=CC=CC=C12 JUXAVSAMVBLDKO-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Gastroenterology & Hepatology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Plural Heterocyclic Compounds (AREA)

AT07847384T 2006-12-07 2007-11-27 Spiropiperidinderivate ATE469899T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP06125645		2006-12-07
PCT/EP2007/062857 WO2008068159A1 (en)	2006-12-07	2007-11-27	Spiro-piperidine derivatives

Publications (1)

Publication Number	Publication Date
ATE469899T1 true ATE469899T1 (de)	2010-06-15

Family

ID=39201604

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT07847384T ATE469899T1 (de)	2006-12-07	2007-11-27	Spiropiperidinderivate

Country Status (21)

Country	Link
US (2)	US7432259B2 (de)
EP (1)	EP2099799B1 (de)
JP (1)	JP2010511654A (de)
KR (1)	KR101111022B1 (de)
CN (1)	CN101541797A (de)
AR (1)	AR064136A1 (de)
AT (1)	ATE469899T1 (de)
AU (1)	AU2007329066B2 (de)
BR (1)	BRPI0720246A2 (de)
CA (1)	CA2670671A1 (de)
CL (1)	CL2007003483A1 (de)
DE (1)	DE602007006989D1 (de)
ES (1)	ES2343286T3 (de)
IL (1)	IL198549A0 (de)
MX (1)	MX2009005507A (de)
NO (1)	NO20091766L (de)
PE (1)	PE20081489A1 (de)
RU (1)	RU2009119393A (de)
TW (1)	TW200843758A (de)
WO (1)	WO2008068159A1 (de)
ZA (1)	ZA200903175B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101273046B (zh) *	2005-09-28	2011-05-25	弗·哈夫曼-拉罗切有限公司	作为加压素受体拮抗剂的吲哚-3-基-羰基氮杂螺环衍生物
WO2010086259A1 (en) *	2009-01-30	2010-08-05	F. Hoffmann-La Roche Ag	Piperidine derivatives as nk3 receptor antagonists
US8324250B2 (en) *	2009-03-19	2012-12-04	Hoffmann-La Roche Inc.	Piperidine derivatives as NK3 receptor antagonists
LT3083633T (lt) *	2013-12-19	2018-02-12	F. Hoffmann-La Roche Ag	Spiro-oksazolonai
US10538530B2 (en) *	2017-09-05	2020-01-21	Blackthorn Therapeutics, Inc.	Vasopressin receptor antagonists and products and methods related thereto
WO2020048831A1 (en)	2018-09-03	2020-03-12	Bayer Aktiengesellschaft	5-aryl-3,9-diazaspiro[5.5]undecan-2-one compounds
WO2020048830A1 (en)	2018-09-03	2020-03-12	Bayer Aktiengesellschaft	5-aryl-3,9-diazaspiro[5.5]undecan-2-one compounds
WO2020048828A1 (en)	2018-09-03	2020-03-12	Bayer Pharma Aktiengesellschaft	5-heteroaryl-3,9-diazaspiro[5.5]undecane compounds
WO2020048826A1 (en)	2018-09-03	2020-03-12	Bayer Aktiengesellschaft	5-substituted 1-oxa-3,9-diazaspiro[5.5]undecan-2-one compounds
WO2020048829A1 (en)	2018-09-03	2020-03-12	Bayer Aktiengesellschaft	3,9-diazaspiro[5.5]undecane compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CO5150201A1 (es)	1998-09-07	2002-04-29	Hoffmann La Roche	Derivados de piperidina
ATE255578T1 (de)	2000-05-12	2003-12-15	Solvay Pharm Bv	Piperazin- und piperidinverbindungen
US7582761B2 (en)	2002-10-17	2009-09-01	Amgen Inc.	Vanilloid receptor ligands and their use in treatments
BRPI0417267A (pt) *	2003-12-22	2007-04-17	Pfizer	derivados de triazol como antagonistas de vasopressina
US7351706B2 (en) *	2006-01-05	2008-04-01	Hoffmann-La Roche Inc.	Indol-3-yl-carbonyl-spiro-piperidine derivatives

2007
- 2007-11-27 AT AT07847384T patent/ATE469899T1/de active
- 2007-11-27 ES ES07847384T patent/ES2343286T3/es active Active
- 2007-11-27 CA CA002670671A patent/CA2670671A1/en not_active Abandoned
- 2007-11-27 WO PCT/EP2007/062857 patent/WO2008068159A1/en not_active Ceased
- 2007-11-27 CN CNA2007800432751A patent/CN101541797A/zh active Pending
- 2007-11-27 RU RU2009119393/04A patent/RU2009119393A/ru not_active Application Discontinuation
- 2007-11-27 AU AU2007329066A patent/AU2007329066B2/en not_active Ceased
- 2007-11-27 KR KR1020097011663A patent/KR101111022B1/ko not_active Expired - Fee Related
- 2007-11-27 DE DE602007006989T patent/DE602007006989D1/de active Active
- 2007-11-27 BR BRPI0720246-6A patent/BRPI0720246A2/pt not_active IP Right Cessation
- 2007-11-27 MX MX2009005507A patent/MX2009005507A/es active IP Right Grant
- 2007-11-27 EP EP07847384A patent/EP2099799B1/de not_active Not-in-force
- 2007-11-27 JP JP2009539698A patent/JP2010511654A/ja not_active Ceased
- 2007-11-30 US US11/947,822 patent/US7432259B2/en not_active Expired - Fee Related
- 2007-11-30 US US11/947,836 patent/US8022213B2/en not_active Expired - Fee Related
- 2007-12-04 CL CL200703483A patent/CL2007003483A1/es unknown
- 2007-12-04 TW TW096146110A patent/TW200843758A/zh unknown
- 2007-12-05 AR ARP070105427A patent/AR064136A1/es unknown
- 2007-12-06 PE PE2007001737A patent/PE20081489A1/es not_active Application Discontinuation
2009
- 2009-05-04 IL IL198549A patent/IL198549A0/en unknown
- 2009-05-05 NO NO20091766A patent/NO20091766L/no not_active Application Discontinuation
- 2009-05-07 ZA ZA200903175A patent/ZA200903175B/xx unknown

Also Published As

Publication number	Publication date
ZA200903175B (en)	2010-03-31
MX2009005507A (es)	2009-06-03
WO2008068159A1 (en)	2008-06-12
US20080161298A1 (en)	2008-07-03
IL198549A0 (en)	2010-02-17
ES2343286T3 (es)	2010-07-27
CL2007003483A1 (es)	2008-07-04
CA2670671A1 (en)	2008-06-12
NO20091766L (no)	2009-07-06
EP2099799B1 (de)	2010-06-02
AR064136A1 (es)	2009-03-18
EP2099799A1 (de)	2009-09-16
BRPI0720246A2 (pt)	2013-12-31
TW200843758A (en)	2008-11-16
US8022213B2 (en)	2011-09-20
KR101111022B1 (ko)	2012-03-14
US20080161299A1 (en)	2008-07-03
AU2007329066A1 (en)	2008-06-12
DE602007006989D1 (en)	2010-07-15
AU2007329066B2 (en)	2012-04-12
CN101541797A (zh)	2009-09-23
JP2010511654A (ja)	2010-04-15
US7432259B2 (en)	2008-10-07
PE20081489A1 (es)	2008-10-30
RU2009119393A (ru)	2011-01-20
KR20090080112A (ko)	2009-07-23

Legal Events

Date

Code

Title

Description

2010-11-15

UEP

Publication of translation of european patent specification

Ref document number: 2099799

Country of ref document: EP

Publication	Publication Date	Title
DK2016080T3 (da)	2010-11-22	Dihydropyrazolopyrimidinon-derivater
ATE483711T1 (de)	2010-10-15	Spiroindolinonderivate
ATE469905T1 (de)	2010-06-15	Pyridopyrimidinonderivate
ATE512135T1 (de)	2011-06-15	Spiroindolinonderivate
DK2035394T3 (da)	2009-10-05	2-pyrazincarboxamidderivater
DK2164844T3 (da)	2012-08-20	Pyrimidinyl-pyridazinonderivater
DK2209786T3 (da)	2013-06-03	Pyrimidinsubstituerede purinderivater
BRPI0820112A2 (pt)	2015-05-05	Derivados de isoxazol-piridina
BRPI0809992A2 (pt)	2014-10-14	Derivados de pirrolopirimidina
BRPI0820113A2 (pt)	2015-05-05	Derivados de isoxazolo-piridazina
DK2125827T3 (da)	2010-12-20	Azaspiroderivater
BRPI0813836A2 (pt)	2015-01-06	Derivados pirazólicos
BRPI0812155A2 (pt)	2019-09-24	derivados de espiroindolinona
BRPI0817935A2 (pt)	2015-04-07	Derivados de biarila
AT504580A3 (de)	2008-07-15	Scan-einrichtung
BRPI0814236A2 (pt)	2015-01-06	Derivados de quinazolinamida
ATE518837T1 (de)	2011-08-15	Indazolamidderivate
BRPI0820649A2 (pt)	2015-06-16	Derivados de isoxazalo-pirazina
DK2152370T3 (da)	2011-08-15	Aryletherpyridazinonderivater
ATE546437T1 (de)	2012-03-15	Aminomethyl-4-imidazole
ATE536356T1 (de)	2011-12-15	Spiropiperidin-glycinamid-derivate
ATE544764T1 (de)	2012-02-15	5-hydroxymethyloxazolidin-2-onderivate
ATE469899T1 (de)	2010-06-15	Spiropiperidinderivate
DE602007001593D1 (de)	2009-08-27	Aryl-/alkylvinylsulfon-hyaluronsäurederivate
ATE519760T1 (de)	2011-08-15	Isoxazolimidazolderivate